GRDX
GRDX
NASDAQ · Biotechnology

Gridai Technologies Corp

Penny Stocks Biotech Stocks Healthcare Stocks
$3.47
+0.04 (+1.17%)
As of Sep 28, 10:41 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,145.0% upside
Low Target $28.55
Average Target $43.20
High Target $44.32
Current Price $3.47
Current
$3.47
Target
$43.20
$28.55 $43.20 avg $44.32
Scenario Analysis
Bear Case
$28.55
722.8%
Low target
Base Case
$43.20
+1,145.0%
Avg target
Bull Case
$44.32
+1,177.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$6.93
-49.9% from high
52-Week Low
$1.87
+85.6% from low
Target vs 52W High
$43.20
+523.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.4%